In Crisis? Call or Text 988

Publications and Digital Products

Your browser is not supported

Switch to Chrome, Edge, Firefox or Safari

Naloxone Saturation Policy Academy Retrospective Report

Naloxone Saturation Policy Academy Retrospective Report
Report summarizes the materials from the Naloxone Saturation Policy Academies (NSPA) three cohorts of 26 states, DC, and Puerto Rico into a single summary report that can be shared with state and other leaders. It includes six state spotlights highlighting work done since the policy academy.

This content is undergoing Section 508 remediation. If you need assistance to access this file, please contact 508@samhsa.hhs.gov.
Publication ID
PEP25-02-009
Publication Date
 

Recommend

You May Also Be Interested In

Support for Use of Naloxone and Other Opioid Overdose Reversal Medications to Prevent Overdose Deaths publication cover

Support for Use of Naloxone and Other Opioid Overdose Reversal Medications to Prevent Overdose Deaths

Monitoring the distribution and impact of opioid overdose reversal medications such as naloxone is essential to optimizing overdose prevention strategies and improving public health outcomes. This Statistical Data Profile, the first to use performance data from two SAMHSA grant programs, examines the distribution of FDA-approved opioid overdose reversal medications, including naloxone/Narcan. The Data Profile also presents the training of first responders, community organization staff and other individuals to administer the reversal medications and provide other support services.

Community Opioid Overdose Reversal Medications (OORMs) Planning Toolkit

Community Opioid Overdose Reversal Medications (OORMs) Planning Toolkit

This comprehensive resource is designed to help communities expand access to lifesaving medications like naloxone to reduce overdose fatalities. The toolkit provides actionable guidance for community leaders, public health professionals, and other partners to create effective overdose prevention and response strategies to improve local overdose reduction outcomes.
National Guidance on Essential Specialty Substance Use Disorder (SUD) Care

National Guidance on Essential Specialty Substance Use Disorder (SUD) Care

SAMHSA’s new National Guidance on Essential Specialty Substance Use Disorder (SUD) Care articulates a core or essential set of services for adults with SUD that should be available at any specialty SUD treatment facility in the United States.
Guidelines for Implementing Medications for Opioid Use Disorder Treatment in State Prisons

Guidelines for Implementing Medications for Opioid Use Disorder Treatment in State Prisons

The Guidelines address the implementation of medications for opioid use disorder (MOUD) in state prisons and practical information about medications, service delivery models, regulatory requirements, staff training, and cultural issues that may affect the uptake and integration of MOUD.

Advisory: Clinical Considerations for Methadone Treatment of Opioid Use Disorder in Correctional Facilities

Advisory: Clinical Considerations for Methadone Treatment of Opioid Use Disorder in Correctional Facilities

This Advisory highlights the importance of methadone as a tool for treating incarcerated with people with opioid use disorder (OUD). The Advisory describes different institutional arrangements for providing methadone in correctional settings.

Advisory: Expanding Access to Methadone Treatment in Hospital Settings

Advisory: Expanding Access to Methadone Treatment in Hospital Settings

This Advisory provides comprehensive information for hospitals and associated healthcare facilities on best practices and recommendations for implementing and expanding treatment of opioid use disorder with methadone in these settings.
Source: https://library.samhsa.gov/product/naloxone-saturation-policy-academy-retrospective-report/pep25-02-009